Sign In
Buy TGTX
$40.11
+3.47 (+9.47%)
At Close: Jun 03, 2026
TG Therapeutics: Elucidating The Upcoming Binary
08:20am, Sunday, 09'th Oct 2022
As a turnaround play, TG Therapeutics has an extremely high-risk profile with correspondingly high rewards. The lead medicine ublituximab is going to the FDA for a potential approval this December as
TG Therapeutics: We Are Just Hanging In There
12:51pm, Wednesday, 21'st Sep 2022
2022 has been a terrible year for a once-promising TGTX. Maybe the FDA decision on December 28 will help us break even.
TG Therapeutics to Participate in the H.C. Wainwright 24th Annual Global Investment Conference
11:30am, Friday, 09'th Sep 2022 GlobeNewswire Inc.
Fireside chat available for on demand download beginning Monday, September 12 2022 at 7:00 AM ET Fireside chat available for on demand download beginning Monday, September 12 2022 at 7:00 AM ET
TG Therapeutics to Participate in the H.C. Wainwright 24th Annual Global Investment Conference
07:30am, Friday, 09'th Sep 2022
Fireside chat available for on demand download beginning Monday, September 12 2022 at 7:00 AM ET Fireside chat available for on demand download beginning Monday, September 12 2022 at 7:00 AM ET
Wall Street Analysts Predict a 225% Upside in TG Therapeutics (TGTX): Here's What You Should Know
01:55pm, Monday, 29'th Aug 2022 Zacks Investment Research
The consensus price target hints at a 225.4% upside potential for TG Therapeutics (TGTX). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings
TG Therapeutics Announces Results from the ULTIMATE I & II Phase 3 Trials of Investigational Ublituximab in RMS Published in The New England Journal of Medicine
11:30am, Thursday, 25'th Aug 2022 GlobeNewswire Inc.
Ublituximab is an investigational targeted B-cell therapy that shows superior efficacy when compared with teriflunomide, a commonly prescribed oral treatment for multiple sclerosis
Can TG Therapeutics (TGTX) Climb 193% to Reach the Level Wall Street Analysts Expect?
01:55pm, Friday, 12'th Aug 2022 Zacks Investment Research
The mean of analysts' price targets for TG Therapeutics (TGTX) points to a 192.6% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among
Why Karuna Therapeutics Jumped Around 72%; Here Are 96 Biggest Movers From Yesterday
07:24am, Tuesday, 09'th Aug 2022 Benzinga
Gainers
Helbiz, Inc. (NASDAQ: HLBZ) jumped 114.6% to close at $1.61 on Monday after climbing over 27% on Friday.
TOP Financial Group Limited (NASDAQ: TOP) jumped 102.7% to settle at $20.57 after gain
Why CinCor Pharma Is Trading Higher By 63%, Here Are 79 Stocks Moving In Monday's Mid-Day Session
04:49pm, Monday, 08'th Aug 2022 Benzinga
Gainers
Bonso Electronics International Inc. (NASDAQ: BNSO) shares jumped 132% to $11.12 after jumping around 46% on Friday. The company recently said it expects unaudited comprehensive loss of $1.6
TG Therapeutics, Inc. (TGTX) CEO Michael Weiss on Q2 2022 Results - Earnings Call Transcript
02:24pm, Monday, 08'th Aug 2022
TG Therapeutics, Inc. (NASDAQ:TGTX ) Q2 2022 Earnings Conference Call August 8, 2022 8:30 AM ET Company Participants Jenna Bosco - Senior Vice President of Corporate Communications Adam Waldman - Chie
TG Therapeutics (TGTX) Reports Q2 Loss, Tops Revenue Estimates
12:45pm, Monday, 08'th Aug 2022 Zacks Investment Research
TG Therapeutics (TGTX) delivered earnings and revenue surprises of 38.78% and 590.70%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
TG Therapeutics Provides Business Update and Reports Second Quarter 2022 Financial Results
11:30am, Monday, 08'th Aug 2022 GlobeNewswire Inc.
Conference call to be held today, August 8, 2022 at 8:30 AM ET Conference call to be held today, August 8, 2022 at 8:30 AM ET
TG Therapeutics (TGTX) Reports Q2 Loss, Tops Revenue Estimates
09:47am, Monday, 08'th Aug 2022
TG Therapeutics (TGTX) delivered earnings and revenue surprises of 38.78% and 590.70%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
TG Therapeutics to Host Conference Call on Second Quarter 2022 Financial Results and Business Update
11:30am, Friday, 05'th Aug 2022 GlobeNewswire Inc.
Conference call to be held Monday, August 8, 2022 at 8:30 AM ET Conference call to be held Monday, August 8, 2022 at 8:30 AM ET
TG Therapeutics to Host Conference Call on Second Quarter 2022 Financial Results and Business Update
07:30am, Friday, 05'th Aug 2022
Conference call to be held Monday, August 8, 2022 at 8:30 AM ET Conference call to be held Monday, August 8, 2022 at 8:30 AM ET
